Wen-Hao Niu1, Feng Wu2, Wen-Yue Cao3, Zong-Gui Wu1, Yu-Chieh Chao4, Chun Liang1. 1. Department of Cardiology, Shanghai Changzheng Hospital, Naval Medical University, Shanghai 200001, China. 2. Department of Cardiology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Affiliated hospital of Shanghai University of Traditional Chinese Medicine, Shanghai 200080, China. 3. Department of Ultrasound, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai 200030, China. 4. Department of Anesthesiology, Shanghai Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200120, China.
Abstract
OBJECTIVE: ´Three formulas and three medicines,' namely, Jinhua Qinggan Granule, Lianhua Qingwen Capsule, Xuebijing Injection, Qingfei Paidu Decoction, HuaShi BaiDu Formula, and XuanFei BaiDu Granule, were proven to be effective for coronavirus disease 2019 (COVID-19) treatment. The present study aimed to identify the active chemical constituents of this traditional Chinese medicine (TCM) and investigate their mechanisms through interleukin-6 (IL-6) integrating network pharmacological approaches. METHODS: We collected the compounds from all herbal ingredients of the previously mentioned TCM, but those that could down-regulate IL-6 were screened through the network pharmacology approach. Then, we modeled molecular docking to evaluate the binding affinity between compounds and IL-6. Furthermore, we analyzed the biological processes and pathways of compounds. Finally, we screened out the core genes of compounds through the construction of the protein-protein interaction network and the excavation of gene clusters of compounds. RESULTS: The network pharmacology research showed that TCM could decrease IL-6 using several compounds, such as quercetin, ursolic acid, luteolin, and rutin. Molecular docking results showed that the molecular binding affinity with IL-6 of all compounds except γ-aminobutyric acid was < -5.0 kJ/mol, indicating the potential of numerous active compounds in TCM to directly interact with IL-6, leading to an anti-inflammation effect. Finally, Cytoscape 3.7.2 was used to topologize the biological processes and pathways of compounds, revealing potential mechanisms for COVID-19 treatment. CONCLUSION: These results indicated the positive effect of TCM on the prevention and rehabilitation of COVID-19 in at-risk people. Quercetin, ursolic acid, luteolin, and rutin could inhibit COVID-19 by down-regulating IL-6.
OBJECTIVE: ´Three formulas and three medicines,' namely, Jinhua Qinggan Granule, Lianhua Qingwen Capsule, Xuebijing Injection, Qingfei Paidu Decoction, HuaShi BaiDu Formula, and XuanFei BaiDu Granule, were proven to be effective for coronavirus disease 2019 (COVID-19) treatment. The present study aimed to identify the active chemical constituents of this traditional Chinese medicine (TCM) and investigate their mechanisms through interleukin-6 (IL-6) integrating network pharmacological approaches. METHODS: We collected the compounds from all herbal ingredients of the previously mentioned TCM, but those that could down-regulate IL-6 were screened through the network pharmacology approach. Then, we modeled molecular docking to evaluate the binding affinity between compounds and IL-6. Furthermore, we analyzed the biological processes and pathways of compounds. Finally, we screened out the core genes of compounds through the construction of the protein-protein interaction network and the excavation of gene clusters of compounds. RESULTS: The network pharmacology research showed that TCM could decrease IL-6 using several compounds, such as quercetin, ursolic acid, luteolin, and rutin. Molecular docking results showed that the molecular binding affinity with IL-6 of all compounds except γ-aminobutyric acid was < -5.0 kJ/mol, indicating the potential of numerous active compounds in TCM to directly interact with IL-6, leading to an anti-inflammation effect. Finally, Cytoscape 3.7.2 was used to topologize the biological processes and pathways of compounds, revealing potential mechanisms for COVID-19 treatment. CONCLUSION: These results indicated the positive effect of TCM on the prevention and rehabilitation of COVID-19 in at-risk people. Quercetin, ursolic acid, luteolin, and rutin could inhibit COVID-19 by down-regulating IL-6.
Authors: Alexander S Rose; Anthony R Bradley; Yana Valasatava; Jose M Duarte; Andreas Prlic; Peter W Rose Journal: Bioinformatics Date: 2018-11-01 Impact factor: 6.937
Authors: Jéssica A Jesus; João Henrique G Lago; Márcia D Laurenti; Eduardo S Yamamoto; Luiz Felipe D Passero Journal: Evid Based Complement Alternat Med Date: 2015-02-22 Impact factor: 2.629
Authors: Alena Liskova; Marek Samec; Lenka Koklesova; Samson M Samuel; Kevin Zhai; Raghad Khalid Al-Ishaq; Mariam Abotaleb; Vladimir Nosal; Karol Kajo; Milad Ashrafizadeh; Ali Zarrabi; Aranka Brockmueller; Mehdi Shakibaei; Peter Sabaka; Ioana Mozos; David Ullrich; Robert Prosecky; Giampiero La Rocca; Martin Caprnda; Dietrich Büsselberg; Luis Rodrigo; Peter Kruzliak; Peter Kubatka Journal: Biomed Pharmacother Date: 2021-02-25 Impact factor: 7.419